Abstract
EP07.02-06 MIDRIXNEO-LUNG: Safety and Immunogenicity of a Neoantigen-Presenting Autologous Dendritic Cell Therapy in Resected NSCLC Patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have